{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:26Z","timestamp":1792785026500,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["GNT2007912"],"award-info":[{"award-number":["GNT2007912"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NHMRC-AMED 2022 Dementia Collaborative Research","award":["GNT2022203"],"award-info":[{"award-number":["GNT2022203"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association grant","doi-asserted-by":"crossref","award":["AARF1020292"],"award-info":[{"award-number":["AARF1020292"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease resulting in the progressive loss of motor neurons in the brain and spine. More than 95% of cases are pathologically characterized by the cytoplasmic accumulation of hyperphosphorylated and ubiquitinated transactive response DNA-binding protein 43 (TDP-43). Multiple mouse models with TDP-43 accumulation have been developed, however, whether they recapitulate molecular features of ALS pathology is unclear. Given the lack of curative treatment for ALS, there is an urgent need to identify the precise biological processes contributing to disease pathogenesis for the development of effective therapeutic treatments. Thus, in this study we employed label-based untargeted proteomics to characterize the ALS proteome and related biological processes in the spinal cord and brain of TDP-43\n                    <jats:sup>Q331K<\/jats:sup>\n                    mice, a transgenic mouse model of ALS and the motor cortex and the cervical, thoracic, and lumbar spinal cord regions from humans. In humans, we observed highly overlapping responses across the four tissues examined, primarily related to the upregulation of immune processes and the downregulation of mitochondrial function. In contrast, TDP-43\n                    <jats:sup>Q331K<\/jats:sup>\n                    mice demonstrate a lack of enrichment for immune activation and the opposite regulation of mitochondrial processes. A meta-analysis of previously published mouse datasets identified the Ubqln2 knock-out mouse model as showing stronger parallels with our late-stage human ALS. Overall, this study provides in-depth analysis of the site-specific dysregulated proteomes and their associated functional processes across species. Thereby, identifying potential therapeutic targets while emphasizing the limitations of specific mouse models at certain timepoints in recapitulating ALS-related processes for future model development.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-11466-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:51:42Z","timestamp":1759240302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial processes between human and mouse ALS models"],"prefix":"10.1038","volume":"15","author":[{"given":"Alanna G.","family":"Spiteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel R.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf B.","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsiung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Goudey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"11466_CR1","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neubiorev.2021.06.027","volume":"127","author":"F De Marchi","year":"2021","unstructured":"De Marchi, F. et al. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact. Neurosci .Biobehav. Rev. 127, 958\u2013978 (2021).","journal-title":"Neurosci .Biobehav. Rev."},{"key":"11466_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/21678421.2021.2016837","volume":"23","author":"JM Burchardt","year":"2022","unstructured":"Burchardt, J. M. et al. Analysis of incidence of motor neuron disease in England 1998\u20132019: Use of three linked datasets. Amyotroph Lateral Scler Frontotemporal Degener 23, 363\u2013371 (2022).","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11466_CR3","doi-asserted-by":"crossref","unstructured":"O'Brien, D. & Shaw, P.J. New developments in the diagnosis and management of motor neuron disease. Br Med Bull (2024).","DOI":"10.1093\/bmb\/ldae010"},{"key":"11466_CR4","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1007\/s00415-024-12219-1","volume":"271","author":"S Imrell","year":"2024","unstructured":"Imrell, S., Fang, F., Ingre, C. & Sennf\u00e4lt, S. Increased incidence of motor neuron disease in Sweden: A population-based study during 2002\u20132021. J. Neurol. 271, 2730\u20132735 (2024).","journal-title":"J. Neurol."},{"key":"11466_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers, D. R. & Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. Lancet Neurol. 18, 211\u2013220 (2019).","journal-title":"Lancet Neurol."},{"key":"11466_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/14789450.2023.2240513","volume":"20","author":"HJ Suddull","year":"2023","unstructured":"Suddull, H. J., Rosa-Fernandes, L. & Lee, A. How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?. Expert Rev. Proteom. 20, 121\u2013123 (2023).","journal-title":"Expert Rev. Proteom."},{"key":"11466_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.37819\/hb.001.001.0197","volume":"1","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Wang, X. & Xu, B. Advances in human brain proteomics analysis of neurodegenerative diseases. Hum. Brain 1, 21\u201345 (2022).","journal-title":"Hum. Brain"},{"key":"11466_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mcn.2017.07.001","volume":"83","author":"L Heyburn","year":"2017","unstructured":"Heyburn, L. & Moussa, C. E. TDP-43 in the spectrum of MND-FTLD pathologies. Mol. Cell Neurosci. 83, 46\u201354 (2017).","journal-title":"Mol. Cell Neurosci."},{"key":"11466_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/cells9041065","volume":"9","author":"M Kodavati","year":"2020","unstructured":"Kodavati, M., Wang, H. & Hegde, M. L. Altered mitochondrial dynamics in motor neuron disease: An emerging perspective. Cells 9, 1065 (2020).","journal-title":"Cells"},{"key":"11466_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41576-023-00592-y","volume":"24","author":"F Ak\u00e7imen","year":"2023","unstructured":"Ak\u00e7imen, F. et al. Amyotrophic lateral sclerosis: Translating genetic discoveries into therapies. Nat. Rev. Genet. 24, 642\u2013658 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"11466_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1212\/CON.0000000000000535","volume":"23","author":"SA Goutman","year":"2017","unstructured":"Goutman, S. A. Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders. Continuum (Minneap Minn) 23, 1332\u20131359 (2017).","journal-title":"Continuum (Minneap Minn)"},{"key":"11466_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-015-0212-4","volume":"3","author":"JC Mitchell","year":"2015","unstructured":"Mitchell, J. C. et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol. Commun. 3, 36 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"11466_CR13","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1038\/s41598-021-96122-z","volume":"11","author":"JA Watkins","year":"2021","unstructured":"Watkins, J. A., Alix, J. J. P., Shaw, P. J. & Mead, R. J. Extensive phenotypic characterisation of a human TDP-43(Q331K) transgenic mouse model of amyotrophic lateral sclerosis (ALS). Sci. Rep. 11, 16659 (2021).","journal-title":"Sci. Rep."},{"key":"11466_CR14","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1021\/acs.molpharmaceut.3c01089","volume":"21","author":"LM Koehn","year":"2024","unstructured":"Koehn, L. M., Steele, J. R., Schittenhelm, R. B., Turner, B. J. & Nicolazzo, J. A. Sex-dependent changes to the intestinal and hepatic abundance of drug transporters and metabolizing enzymes in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Mol. Pharm. 21, 1756\u20131767 (2024).","journal-title":"Mol. Pharm."},{"key":"11466_CR15","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/pharmaceutics14122803","volume":"14","author":"Y Pan","year":"2022","unstructured":"Pan, Y. et al. Altered blood-brain barrier dynamics in the C9orf72 hexanucleotide repeat expansion mouse model of amyotrophic lateral sclerosis. Pharmaceutics 14, 2803 (2022).","journal-title":"Pharmaceutics"},{"key":"11466_CR16","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1021\/acs.jproteome.4c00294","volume":"23","author":"Y Hsiao","year":"2024","unstructured":"Hsiao, Y. et al. Analysis and visualization of quantitative proteomics data using fragpipe-analyst. J. Proteome Res. 23, 4303\u20134315 (2024).","journal-title":"J. Proteome Res."},{"key":"11466_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1021\/acs.jproteome.9b00496","volume":"19","author":"AD Shah","year":"2020","unstructured":"Shah, A. D., Goode, R. J. A., Huang, C., Powell, D. R. & Schittenhelm, R. B. LFQ-Analyst: An easy-to-use interactive web platform to analyze and visualize label-free proteomics data preprocessed with maxquant. J. Proteome Res. 19, 204\u2013211 (2020).","journal-title":"J. Proteome Res."},{"key":"11466_CR18","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1021\/acs.jproteome.3c00186","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Phospho-analyst: An interactive, easy-to-use web platform to analyze quantitative phosphoproteomics data. J. Proteome Res. 22, 2890\u20132899 (2023).","journal-title":"J. Proteome Res."},{"key":"11466_CR19","doi-asserted-by":"crossref","unstructured":"Smyth, G.K. limma: Linear Models for Microarray Data. In: Gentleman, R., Carey, V.J., Huber, W., Irizarry, R.A. & Dudoit, S. (eds). Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Springer New York: New York NY 397\u2013420 (2005)","DOI":"10.1007\/0-387-29362-0_23"},{"key":"11466_CR20","doi-asserted-by":"publisher","first-page":"btad526","DOI":"10.1093\/bioinformatics\/btad526","volume":"39","author":"ZH Feng","year":"2023","unstructured":"Feng, Z. H., Fang, P. Y., Zheng, H. & Zhang, X. F. DEP2: An upgraded comprehensive analysis toolkit for quantitative proteomics data. Bioinformatics 39, btad526 (2023).","journal-title":"Bioinformatics"},{"key":"11466_CR21","doi-asserted-by":"crossref","unstructured":"Wu, T.Z. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation-Amsterdam 2 (2021).","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"11466_CR22","unstructured":"Yu, G. enrichplot: Visualization of Functional Enrichment Result. (2023)."},{"key":"11466_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene Ontology: Tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"11466_CR24","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"Aleksander, S. A. et al. The gene ontology knowledgebase in 2023. Genetics 224, iyad031 (2023).","journal-title":"Genetics"},{"key":"11466_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"11466_CR26","unstructured":"Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res (2023)."},{"key":"11466_CR27","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1074\/mcp.TIR120.002155","volume":"19","author":"J Griss","year":"2020","unstructured":"Griss, J. et al. ReactomeGSA-efficient multi-omics comparative pathway analysis. Mol. Cell Proteom. 19, 2115 (2020).","journal-title":"Mol. Cell Proteom."},{"key":"11466_CR28","doi-asserted-by":"publisher","first-page":"D1539","DOI":"10.1093\/nar\/gkac1040","volume":"51","author":"EW Deutsch","year":"2022","unstructured":"Deutsch, E. W. et al. The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res. 51, D1539\u2013D1548 (2022).","journal-title":"Nucleic Acids Res."},{"key":"11466_CR29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015960","volume":"296","author":"AM Whiteley","year":"2021","unstructured":"Whiteley, A. M. et al. Global proteomics of Ubqln2-based murine models of ALS. J Biol.. Chem. 296, 100153 (2021).","journal-title":"J Biol.. Chem."},{"key":"11466_CR30","first-page":"135","volume":"25","author":"A Matveeva","year":"2024","unstructured":"Matveeva, A. et al. Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS\/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders. Amyotroph. Lat. Scl. Fr. 25, 135\u2013149 (2024).","journal-title":"Amyotroph. Lat. Scl. Fr."},{"key":"11466_CR31","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1038\/s41467-024-49196-y","volume":"15","author":"LC Gomes","year":"2024","unstructured":"Gomes, L. C. et al. Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target. Nat. Commun. 15, 4893 (2024).","journal-title":"Nat. Commun."},{"key":"11466_CR32","unstructured":"San Gil, R. et al. A transient protein folding response targets aggregation in the early"},{"key":"11466_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart, F., Gautier, B., Singh, A. & Le Cao, K. A. mixOmics: An R package for \u2019omics feature selection and multiple data integration. PLoS Comput. Biol. 13, e1005752 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"11466_CR34","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: An R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938\u20132940 (2017).","journal-title":"Bioinformatics"},{"key":"11466_CR35","first-page":"726","volume":"1","author":"R Kolde","year":"2019","unstructured":"Kolde, R. Pheatmap: Pretty heatmaps. R Packag. Version 1, 726 (2019).","journal-title":"R Packag. Version"},{"key":"11466_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh, M. E. et al. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol. Med. 10, 48\u201362 (2018).","journal-title":"EMBO Mol. Med."},{"key":"11466_CR37","first-page":"177","volume":"19","author":"R Rudolf","year":"2016","unstructured":"Rudolf, R., Deschenes, M. R. & Sandri, M. Neuromuscular junction degeneration in muscle wasting. Curr. Opin. Clin. Nutr.. Metab Care 19, 177\u2013181 (2016).","journal-title":"Curr. Opin. Clin. Nutr.. Metab Care"},{"key":"11466_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1113\/JP270213","volume":"595","author":"D Arbour","year":"2017","unstructured":"Arbour, D., Vande Velde, C. & Robitaille, R. New perspectives on amyotrophic lateral sclerosis: The role of glial cells at the neuromuscular junction. J. Physiol. 595, 647\u2013661 (2017).","journal-title":"J. Physiol."},{"key":"11466_CR39","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/brain\/awae074","volume":"147","author":"EL Clayton","year":"2024","unstructured":"Clayton, E. L., Huggon, L., Cousin, M. A. & Mizielinska, S. Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis. Brain 147, 2289\u20132307 (2024).","journal-title":"Brain"},{"key":"11466_CR40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/jnc.13763","volume":"139","author":"L Heyburn","year":"2016","unstructured":"Heyburn, L. et al. Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis. J. Neurochem. 139, 610\u2013623 (2016).","journal-title":"J. Neurochem."},{"key":"11466_CR41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1471-4159.2007.05190.x","volume":"105","author":"IF Wang","year":"2008","unstructured":"Wang, I. F., Wu, L. S., Chang, H. Y. & Shen, C. K. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J. Neurochem. 105, 797\u2013806 (2008).","journal-title":"J. Neurochem."},{"key":"11466_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120753","volume":"452","author":"A Lee","year":"2023","unstructured":"Lee, A., Henderson, R., Arachchige, B. J., Robertson, T. & McCombe, P. A. Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms. J. Neurol. Sci. 452, 120753 (2023).","journal-title":"J. Neurol. Sci."},{"key":"11466_CR43","doi-asserted-by":"publisher","first-page":"fcaa124","DOI":"10.1093\/braincomms\/fcaa124","volume":"2","author":"LC Beland","year":"2020","unstructured":"Beland, L. C. et al. Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2, fcaa124 (2020).","journal-title":"Brain Commun."},{"key":"11466_CR44","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1038\/s41598-019-40632-4","volume":"9","author":"E Leoni","year":"2019","unstructured":"Leoni, E. et al. Combined tissue-fluid proteomics to unravel phenotypic variability in amyotrophic lateral sclerosis. Sci. Rep. 9, 4478 (2019).","journal-title":"Sci. Rep."},{"key":"11466_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","volume":"210","author":"S Mantovani","year":"2009","unstructured":"Mantovani, S. et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J. Neuroimmunol. 210, 73\u201379 (2009).","journal-title":"J. Neuroimmunol."},{"key":"11466_CR46","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani, S. et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat. Commun. 13, 6733 (2022).","journal-title":"Nat. Commun."},{"key":"11466_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","volume":"21","author":"KJ Spiller","year":"2018","unstructured":"Spiller, K. J. et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 21, 329\u2013340 (2018).","journal-title":"Nat. Neurosci."},{"key":"11466_CR48","doi-asserted-by":"publisher","first-page":"1138995","DOI":"10.3389\/fonc.2023.1138995","volume":"13","author":"G Li","year":"2023","unstructured":"Li, G. et al. SAA1 identified as a potential prediction biomarker for metastasis of hepatocellular carcinoma via multi-omics approaches. Front. Oncol. 13, 1138995 (2023).","journal-title":"Front. Oncol."},{"issue":"3","key":"11466_CR49","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/rheumatology\/keae187","volume":"64","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. SERPINA3, FGA, AGP1, ITIH3 and SAA1 as novel biomarkers for eosinophilic granulomatosis with polyangiitis diagnosis and activity assessment. Rheumatology 64(3), 1316\u20131325 (2024).","journal-title":"Rheumatology"},{"key":"11466_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jaip.2023.09.004","volume":"12","author":"A Carvallo","year":"2024","unstructured":"Carvallo, A. et al. Serum amyloid a as a potential biomarker for disease activity in chronic spontaneous urticaria. J. Allergy Clin. Immunol. Pract. 12, 195\u2013200 (2024).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"11466_CR51","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/ijms25021177","volume":"25","author":"M Stute","year":"2024","unstructured":"Stute, M., Kreysing, M., Zorn, M., Michl, P. & Gauss, A. Serum Amyloid a as a potential biomarker in inflammatory bowel diseases, especially in patients with low c-reactive protein. Int. J. Mol. Sci. 25, 1177 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"11466_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.631299","volume":"11","author":"I Sori\u0107 Hosman","year":"2020","unstructured":"Sori\u0107 Hosman, I., Kos, I. & Lamot, L. Serum amyloid A in inflammatory rheumatic diseases: A compendious review of a renowned biomarker. Front. Immunol. 11, 631299 (2020).","journal-title":"Front. Immunol."},{"key":"11466_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jinf.2020.03.035","volume":"80","author":"H Li","year":"2020","unstructured":"Li, H. et al. Serum amyloid A is a biomarker of severe coronavirus disease and poor prognosis. J. Infect. 80, 646\u2013655 (2020).","journal-title":"J. Infect."},{"key":"11466_CR54","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jcmgh.2021.06.016","volume":"12","author":"TA Davis","year":"2021","unstructured":"Davis, T. A. et al. Serum amyloid A promotes inflammation-associated damage and tumorigenesis in a mouse model of colitis-associated cancer. Cell. Mol. Gastroenterol. Hepatol. 12, 1329\u20131341 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"11466_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clinbiochem.2020.08.005","volume":"85","author":"C Chang","year":"2020","unstructured":"Chang, C., Pan, Y., Du, H., Wang, X. & Li, X. Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome. Clin. Biochem. 85, 27\u201332 (2020).","journal-title":"Clin. Biochem."},{"key":"11466_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41420-023-01455-5","volume":"9","author":"R Chen","year":"2023","unstructured":"Chen, R. et al. Serum amyloid protein A in inflammatory bowel disease: From bench to bedside. Cell Death Discov. 9, 154 (2023).","journal-title":"Cell Death Discov."},{"key":"11466_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0304-3940(97)00196-1","volume":"225","author":"JS Liang","year":"1997","unstructured":"Liang, J. S. et al. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer\u2019s disease brain. Neurosci. Lett. 225, 73\u201376 (1997).","journal-title":"Neurosci. Lett."},{"key":"11466_CR58","doi-asserted-by":"publisher","first-page":"12158","DOI":"10.1038\/s41598-017-12529-7","volume":"7","author":"M Barbierato","year":"2017","unstructured":"Barbierato, M. et al. Expression and differential responsiveness of central nervous system glial cell populations to the acute phase protein serum amyloid A. Sci. Rep. 7, 12158 (2017).","journal-title":"Sci. Rep."},{"key":"11466_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12974-018-1205-6","volume":"15","author":"L Facci","year":"2018","unstructured":"Facci, L., Barbierato, M., Zusso, M., Skaper, S. D. & Giusti, P. Serum amyloid A primes microglia for ATP-dependent interleukin-1\u03b2 release. J. Neuroinflammation 15, 164 (2018).","journal-title":"J. Neuroinflammation"},{"key":"11466_CR60","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200019","volume":"9","author":"JR Thonhoff","year":"2022","unstructured":"Thonhoff, J. R. et al. Combined regulatory T-Lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol. Neuroimmunol. & Neuroinflammation 9, e200019 (2022).","journal-title":"Neurol. Neuroimmunol. & Neuroinflammation"},{"key":"11466_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","volume":"15","author":"JD Lee","year":"2018","unstructured":"Lee, J. D. et al. Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis. J. Neuroinflammation 15, 171 (2018).","journal-title":"J. Neuroinflammation"},{"key":"11466_CR62","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389\u20131392 (2006).","journal-title":"Science"},{"key":"11466_CR63","doi-asserted-by":"publisher","first-page":"10298","DOI":"10.3390\/ijms221910298","volume":"22","author":"MO Mol","year":"2021","unstructured":"Mol, M. O. et al. Molecular pathways involved in frontotemporal lobar degeneration with TDP-43 proteinopathy: What can we learn from proteomics?. Int. J. Mol. Sci. 22, 10298 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"11466_CR64","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","volume":"22","author":"W Wang","year":"2013","unstructured":"Wang, W. et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 22, 4706\u20134719 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"11466_CR65","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22, 869\u2013878 (2016).","journal-title":"Nat. Med."},{"key":"11466_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-023-00619-2","volume":"18","author":"EMC Fisher","year":"2023","unstructured":"Fisher, E. M. C. et al. Opinion: more mouse models and more translation needed for ALS. Mol. Neurodegener. 18, 30 (2023).","journal-title":"Mol. Neurodegener."},{"key":"11466_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00401-021-02384-2","volume":"143","author":"AG Spiteri","year":"2022","unstructured":"Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G. & King, N. J. C. Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function. Acta Neuropathol. 143, 179\u2013224 (2022).","journal-title":"Acta Neuropathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11466-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:22:18Z","timestamp":1759242138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11466-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11466"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11466-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, separately for animal and human studies. All animal experiments are reported in accordance with the ARRIVE guidelines and were approved by the Florey Institute of Neuroscience and Mental Health Animal Ethics Committee (protocol number: 23\u2013011-FINMH). The study was conducted in compliance with the Australian National Health and Medical Research Council Code of Practice. The use of postmortem human tissue was approved by The University of Melbourne Human Research Ethics Committee and Victorian Brain Bank. Informed consent was obtained from all donors, or next of kin prior to collection of tissue.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"33959"}}